Global blood management system market is anticipated to grow at a rapid pace in the forecast period, 2024-2028. Growing awareness among healthcare professionals and the public, coupled with the increasing demand for blood and blood products across the world are the key factors responsible for the growth of the global blood management system market.
A blood management system refers to a set of strategies, techniques, and processes designed to optimize the use of blood products in medical settings. The primary goal of blood management is to ensure patient safety and improve patient outcomes while minimizing the need for blood transfusions. These systems are typically implemented in hospitals, surgical centers, and other healthcare facilities. The other factors which are supporting the growth of the global blood management system market are growing demand for blood donations, rising technological advancements, increasing healthcare expenditure, rising prevalence of blood disorders, rise in number of blood donors, and increase in the number of surgical procedures.
In 2021, the National AIDS Control Organization in India facilitated the collection of approximately 5.83 million blood units through its blood transfusion services. This represented a decline from the previous year, when nearly 7.3 million units were collected.
In 2021, the American Red Cross stated that sickle cell disease affected about 1,00,000 people in the United Stated. These patients require blood transfusion throughout their lives, therefore increasing the demand for blood transfusions.
Download Free Sample ReportGrowing Awareness among Healthcare Professionals and the Public
. For instance, the International Foundation for Patient Blood Management (IFPBM) is a global organization dedicated to promoting patient blood management and improving patient outcomes. They organize educational conferences, workshops, and webinars to raise awareness about the benefits of blood management systems and advocate for their implementation in healthcare settings worldwide.
Technological Advancements
In automation and integration, blood management systems have evolved to automate various processes involved in blood management, including inventory tracking, patient identification, and transfusion documentation. Integration with electronic health records (EHRs) and other healthcare systems enables seamless data exchange, reducing manual errors, improving workflow efficiency, and enhancing patient safety. In scanning and RFID technology, the use of barcode scanning, and radio-frequency identification (RFID) technology has revolutionized blood management systems. Barcodes and RFID tags are used to track and identify blood products throughout the supply chain, ensuring accurate matching with patients, reducing the risk of errors, and enhancing traceability. These technologies streamline processes, improve inventory management, and contribute to overall transfusion safety. Other technological advancements are electronic crossmatching and compatibility testing. Traditional crossmatching and compatibility testing methods are time-consuming and resource intensive. Advanced blood management systems incorporate electronic crossmatching capabilities, using algorithms and patient data to predict blood compatibility, reducing the need for serological testing and expediting the transfusion process. This technology improves turnaround time, reduces costs, and enhances patient care. Also, blood management systems are incorporating decision support systems and predictive analytics to aid healthcare professionals in making informed decisions. These systems analyze patient data, blood product availability, and historical transfusion patterns to provide recommendations for optimal blood utilization, inventory management, and transfusion strategies. By leveraging data insights, healthcare providers can improve patient outcomes, reduce costs, and enhance resource allocation. The use of mobile applications and remote access capabilities have made blood management systems more accessible and convenient for healthcare professionals. With these technologies, healthcare providers can access real-time data, perform tasks remotely, and make critical decisions on the go. Mobile applications enable efficient communication, reduce paperwork, and enhance collaboration among healthcare teams, contributing to improved blood management practices. Furthermore, the incorporation of Artificial Intelligence (AI) and machine learning algorithms are done to optimize various processes in blood management system. These technologies can analyze large volumes of data, identify patterns, and make predictions to support decision-making, inventory forecasting, and personalized transfusion strategies. AI-powered systems can help identify potential adverse events, improve blood product matching, and enhance patient safety. These growing technological advancements are transforming the blood management landscape, and are improving operational efficiency, patient safety, and resource utilization, which in turn, supports the growth of the global blood management systems.
Recent Developments
- In 2022, Terumo Blood and CellTechnologies, received approval from the U.S. Food and Drug Administration(FDA) for a novel plasma collection system. This system is specificallydeveloped to enhance the efficiency of plasma collection, minimizing the timerequired. The FDA approval of this advanced plasma collection system isexpected to bolster Terumo's portfolio in the field of blood and celltechnologies, reinforcing their position in the market.
Market Segmentation
,
Attribute | Details |
Base Year | 2022 |
Historical Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million and CAGR for 2018-2022 and 2023E-2028F |
Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
Segments covered | Type End User Region |
Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
Country scope | United States, Mexico, Canada, China, India, Japan, South Korea, Australia, Germany, France, United Kingdom, Spain, Italy; South Africa, UAE, Saudi Arabia; Brazil, Argentina, Colombia; |
Key companies profiled | Cerner Corporation, Haemonetics Corporation, Coelentera Technologies Pvt. Ltd., Strides Software Solutions Pvt Ltd., McKesson Corporation, Integrated Medical Systems, Inc., MAK-SYSTEM International Group, Mediware, Inc., CompuGroup Medical SE & Co. KGaA, and SCC Soft Computer |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |